Form D — Ollin Biosciences, Inc.
0002141184-26-000002 · filed 2026-06-24
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $330,000,000
- Total sold
- $156,249,990
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ollin Biosciences, Inc.
- CIK
- 2141184
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2022
- Address
- 1250 S. CAPITAL OF TEXAS HWY
AUSTIN, TX 78746 - Phone
- 512-885-4957
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jason Ehrlich · Executive OfficerAUSTIN, TX Find on LinkedIn ↗
-
Paul Berns · DirectorAUSTIN, TX Find on LinkedIn ↗
-
Jason Coloma · DirectorAUSTIN, TX Find on LinkedIn ↗
-
Cariad Chester · DirectorAUSTIN, TX Find on LinkedIn ↗
-
Fred Cohen · DirectorAUSTIN, TX Find on LinkedIn ↗
-
Alaa Halawa · DirectorAUSTIN, TX Find on LinkedIn ↗
-
Travis Murdoch · DirectorAUSTIN, TX Find on LinkedIn ↗
View original on SEC EDGAR.